OpenLB
Open Library of Bioscience
Advanced Search
Advances in dental research
10, 2019;30 (1): 4-10.

Oral Health Effects of Combusted and Smokeless Tobacco Products.

S L Tomar, S S Hecht, I Jaspers, R L Gregory, I Stepanov
Author Information
  1. S L Tomar: College of Dentistry, University of Florida, Gainesville, FL, USA.
  2. S S Hecht: Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
  3. I Jaspers: School of Medicine, University of North Carolina, Chapel Hill, NC, USA.
  4. R L Gregory: School of Dentistry, Indiana University, Indianapolis, IN, USA.
  5. I Stepanov: Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
PMID: 31538806 DOI: 10.1177/0022034519872480

Abstract

The oral cavity is usually the first part of a consumer's body exposed to the constituents of tobacco products or their emissions. Consequently, the oral cavity is a frequent site for carcinogenic, microbial, immunologic, and clinical effects of tobacco use. This article summarizes 5 presentations on various aspects of oral health affected by combusted or noncombusted tobacco products from a recent conference, "Oral Health Effects of Tobacco Products: Science and Regulatory Policy," sponsored by the American Association for Dental Research and the Food and Drug Administration.

Keywords

Streptococcus mutans carcinogenesis electronic nicotine delivery systems mucosal immunity nicotine smoking

References

  1. Carcinogenesis. 2013 Sep;34(9):2178-83 [PMID: 23671129]
  2. Nicotine Tob Res. 2019 Aug 19;21(9):1248-1258 [PMID: 30335174]
  3. Acta Odontol Scand. 1989 Aug;47(4):239-43 [PMID: 2782061]
  4. Sci Rep. 2017 Sep 8;7(1):11044 [PMID: 28887552]
  5. J Oral Microbiol. 2014 Apr 01;6: [PMID: 24765243]
  6. Tob Control. 2014 Mar;23(2):107-12 [PMID: 23117999]
  7. Folia Microbiol (Praha). 2016 Nov;61(6):505-512 [PMID: 27381088]
  8. MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1276-1277 [PMID: 30439875]
  9. Cancer Prev Res (Phila). 2015 Jan;8(1):20-6 [PMID: 25524878]
  10. Chem Res Toxicol. 2017 Feb 20;30(2):540-551 [PMID: 28001416]
  11. Am J Physiol Lung Cell Mol Physiol. 2016 Jul 1;311(1):L135-44 [PMID: 27288488]
  12. Environ Sci Technol. 2016 Sep 6;50(17):9644-51 [PMID: 27461870]
  13. J Dent Sci. 2018 Mar;13(1):30-36 [PMID: 30895091]
  14. Arch Oral Biol. 2015 Aug;60(8):1083-90 [PMID: 25985036]
  15. Caries Res. 2008;42(4):255-62 [PMID: 18523384]
  16. Eur J Oral Sci. 2012 Aug;120(4):319-25 [PMID: 22813222]
  17. Chem Res Toxicol. 2010 Jun 21;23(6):1001-8 [PMID: 20408564]
  18. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt E):1-538 [PMID: 23193840]
  19. Prev Med. 2004 Mar;38(3):309-17 [PMID: 14766113]
  20. Swed Dent J Suppl. 1989;65:1-62 [PMID: 2690396]
  21. Carcinogenesis. 2011 Sep;32(9):1366-71 [PMID: 21734256]
  22. Tob Control. 2016 Nov;25(Suppl 2):ii40-ii49 [PMID: 27856998]
  23. J Evid Based Dent Pract. 2014 Sep;14(3):151-3 [PMID: 25234221]
  24. J Dent Res. 2005 Aug;84(8):705-10 [PMID: 16040726]
  25. IARC Monogr Eval Carcinog Risks Hum. 2004;83:1-1438 [PMID: 15285078]
  26. Tob Control. 2010 Apr;19(2):104-9 [PMID: 20008157]
  27. Am J Respir Crit Care Med. 2018 Jul 1;198(1):67-76 [PMID: 29481290]
  28. IARC Monogr Eval Carcinog Risks Hum. 2007;89:1-592 [PMID: 18335640]
  29. Chem Res Toxicol. 2017 Jan 17;30(1):126-144 [PMID: 28092946]
  30. MMWR Morb Mortal Wkly Rep. 2015 Oct 02;64(38):1066-70 [PMID: 26421418]
  31. J Am Dent Assoc. 1995 Mar;126(3):327-31; quiz 348 [PMID: 7897101]
  32. Otolaryngol Clin North Am. 2011 Feb;44(1):31-56, v [PMID: 21093622]
  33. Am J Respir Crit Care Med. 2018 Feb 15;197(4):492-501 [PMID: 29053025]
  34. Chem Res Toxicol. 1998 Jun;11(6):559-603 [PMID: 9625726]
  35. IARC Monogr Eval Carcinog Risks Hum. 2010;92:1-853 [PMID: 21141735]
  36. Nicotine Tob Res. 2013 Feb;15(2):591-5 [PMID: 22923602]
  37. Arch Oral Biol. 2008 Oct;53(10):969-74 [PMID: 18672230]
  38. Ann Am Thorac Soc. 2014 Jan;11 Suppl 1:S38-42 [PMID: 24437404]
  39. Br Dent J. 2000 Aug 26;189(4):200-6 [PMID: 11036748]
  40. Acta Odontol Scand. 2016 Jul;74(5):385-92 [PMID: 27215270]
  41. Nicotine Tob Res. 2013 Jan;15(1):88-92 [PMID: 22529222]
  42. Nicotine Tob Res. 2012 Jan;14(1):18-28 [PMID: 21324834]
  43. Adv Dent Res. 1997 Sep;11(3):307-12 [PMID: 9524430]
  44. Virulence. 2011 Sep-Oct;2(5):435-44 [PMID: 21778817]
  45. J Am Dent Assoc. 1999 Nov;130(11):1601-10 [PMID: 10573940]
  46. Tob Control. 1997 Autumn;6(3):219-25 [PMID: 9396107]
  47. Toxicol In Vitro. 2014 Mar;28(2):198-208 [PMID: 24516877]
  48. Am J Prev Med. 2017 Aug;53(2):139-151 [PMID: 28318902]
  49. Tob Control. 2016 Nov;25(Suppl 2):ii94-ii102 [PMID: 27633763]
  50. Am J Physiol Lung Cell Mol Physiol. 2017 Aug 1;313(2):L278-L292 [PMID: 28495856]
  51. Caries Res. 2011;45(1):40-6 [PMID: 21228593]
  52. J Periodontol. 2000 May;71(5):743-751 [PMID: 29537517]
  53. Int Dent J. 2010 Feb;60(1):7-30 [PMID: 20361572]
  54. Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L470-L486 [PMID: 30604630]

Grants

  1. R01 CA081301/NCI NIH HHS
  2. R13 FD006142/FDA HHS

MeSH Term

Carcinogens
Humans
Oral Health
Tobacco Products
Tobacco, Smokeless
United States
United States Food and Drug Administration

Chemicals

Carcinogens
Journal Article Research Support, U.S. Gov't, P.H.S. Review
Article has an altmetric score of 5

Word Cloud

Created with Highcharts 10.0.0oraltobaccocavityproductsHealthEffectsTobacconicotineusuallyfirstpartconsumer'sbodyexposedconstituentsemissionsConsequentlyfrequentsitecarcinogenicmicrobialimmunologicclinicaleffectsusearticlesummarizes5presentationsvariousaspectshealthaffectedcombustednoncombustedrecentconference"OralProducts:ScienceRegulatoryPolicy"sponsoredAmericanAssociationDentalResearchFoodDrugAdministrationOralCombustedSmokelessProductsStreptococcusmutanscarcinogenesiselectronicdeliverysystemsmucosalimmunitysmoking

Similar Articles

Cited By